Raymond James downgraded HCA from Outperform to Mkt Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2025 | $470.00 | Buy | Goldman |
| 7/28/2025 | Outperform → Peer Perform | Wolfe Research | |
| 7/16/2025 | $394.00 | Buy → Neutral | BofA Securities |
| 5/29/2025 | $385.00 | Underweight → Equal Weight | Wells Fargo |
| 4/15/2025 | $336.00 | Outperform → Neutral | Robert W. Baird |
| 12/17/2024 | $380.00 | Neutral | Analyst |
| 11/25/2024 | $400.00 → $320.00 | Equal Weight → Underweight | Wells Fargo |
| 11/22/2024 | Outperform → Mkt Perform | Raymond James |
HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conferences: November 12, 2025 at 9:30am ET at the 2025 UBS Global Healthcare Conference November 17, 2025 at 12:00pm ET at the 2025 Wolfe Research Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's website for the latest information. About HCA Healthcare Nashville-based HCA Healthcare is one o
HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program (which may be reborrowed from time to time), and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.500 billion outstanding aggre
Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share Adjusted EBITDA increased 18.5 percent to $3.870 billion Cash flows from operating activities totaled $4.416 billion,
Goldman resumed coverage of HCA with a rating of Buy and set a new price target of $470.00
Wolfe Research downgraded HCA from Outperform to Peer Perform
BofA Securities downgraded HCA from Buy to Neutral and set a new price target of $394.00
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
3 - HCA Healthcare, Inc. (0000860730) (Issuer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
FWP - HCA Healthcare, Inc. (0000860730) (Subject)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction—comprising the Frist Humanitarian Award and the Excellence in Nursing Award—are the highest honors HCA Healthcare bestows on employees, physicians and volunteers, recognizing the extraordinary individuals who exemplify the organization's culture and values. The Frist Humanitarian Award recognizes the highest achievements in serving others, and the HCA Healthcare Excellence in Nursing Award recognizes the highest levels of performance in the field of nursing. "The
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare's board of directors increases from nine to ten members. Mr. Chidsey will serve as a member of HCA Healthcare's audit and compliance committee, compensation committee and patient safety and quality of care committee. Mr. Chidsey most recently served as the global chief executive officer of Subway. He previously served as chief executive officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com
Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share Adjusted EBITDA increased 18.5 percent to $3.870 billion Cash flows from operating activities totaled $4.416 billion,
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2025 Earnings Call When: Friday, October 24, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news
Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): Revenues increased 6.4 percent to $18.605 billion Net income attributable to HCA Healthcare, Inc. increased 13.1 percent to $1.653 billion Diluted earnings per share increased 23.5 percent to $6.83 per diluted share, and diluted earnings per share, as adjusted, increased 24.4 percent to $6.84 per diluted share Adjusted EBITDA increased 8.4 percent to $3.849 billion Cash flows from operating activities totaled $4.210 billion, com
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)